CC1=CN(S(=O)(=O)c2ccc(C)cc2)C[C@@H]2[C@H]3CC[C@H](C3)[C@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?